AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Naltrexone injectable (Vivitrol) for opioid dependence.(From the FDA)

The Brown University Child and Adolescent Psychopharmacology Update

| January 01, 2011 | (Hide copyright information)Copyright

A once-monthly extended-release formulation of naltrexone (Vivitrol) delivered by intramuscular injection was approved by the FDA on October 12. Vivitrol is indicated for treatment and relapse …

Related articles from newspapers, magazines, journals, and more
Approval: naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
Magazine article from: Brown University Psychopharmacology Update June 1, 2006 700+ words
Approval: Naltrexone injectable suspension (Vivitrol).(From the FDA)(Brief...
Newspaper article from: The Brown University Geriatric Psychopharmacology Update June 1, 2006 700+ words
Naltrexone injectable (Vivitrol) approved for opioid dependence.(From the...
Magazine article from: Brown University Psychopharmacology Update December 1, 2010 700+ words
Approval: naltrexone extended-release injectable (Vivitrol).(From the...
Newspaper article from: The Brown University Child and Adolescent Psychopharmacology Update June 1, 2006 700+ words
Medication depends on type of alcoholism, says researcher.
Newspaper article from: Alcoholism & Drug Abuse Weekly June 7, 2010 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily